close
MENU
Tech & Innovation
6 mins to read

Mark Weldon, two Daves, & some Kiwi bankers: backing Ruminant Bio

Those behind the New Zealand-based agritech company developing a world-leading methane-inhibiting bolus for ruminant animals.

Ruminant BioTechs latest trial on cattle showed a 75 daily methane reduction for 100 days from its biodegradable bolus.

In a recent US podcast, Ruminant BioTech chair and shareholder Mark Weldon was asked about the genesis of the company that is developing a slow-release, methane-inhibiting bolus for ruminant animals globally.

It’s hoping to deliver a commercially ready bolus in 2025 into the Australian

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Fiona Rotherham Fri, 30 Aug 2024
Contact the Writer: fiona@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Mark Weldon, two Daves, & some Kiwi bankers: backing Ruminant Bio
Tech & Innovation,
105623
true